Persistence of Pseudomonas aeruginosa in a pulmonary nodule with late relapse

S Ronkainen1, Y Xie, M Battiwalla

  • 1Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Insights

Pseudomonas aeruginosa can persist in quiescent lung nodules for months after treatment in transplant patients. These nodules may harbor viable bacteria, leading to recurrent infections and posing diagnostic challenges.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Transplantation Medicine

Background:

  • Lung nodules are frequent diagnostic challenges in hematopoietic stem cell transplantation (HSCT) and solid organ transplantation (SOT).
  • Pseudomonas aeruginosa (P. aeruginosa) is a recognized cause of lung abscess in immunocompromised patients, but its long-term persistence in pulmonary nodules is poorly understood.

Observation:

  • A patient with acute pre-B-cell lymphoblastic leukemia post-allogeneic HSCT developed nodule enlargement and cavitation 10 months after transplantation.
  • This nodule was a remnant of a presumed P. aeruginosa septic embolus from 2.5 months post-transplant.
  • The nodule subsequently shrank to <1 cm with antibiotic treatment, remaining stable.

Findings:

  • Transthoracic needle aspiration of the nodule yielded P. aeruginosa.
  • Molecular typing confirmed the isolates were indistinguishable from those previously found in the patient's blood and bronchoalveolar lavage fluid.
  • This demonstrates P. aeruginosa can remain viable within pulmonary nodules long after initial treatment.

Implications:

  • Sub-centimeter pulmonary nodules post-P. aeruginosa infection may harbor viable organisms.
  • These nodules can serve as a nidus for recrudescent infection in transplant recipients.
  • This highlights the importance of considering persistent bacterial reservoirs in managing lung infections in immunocompromised populations.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
80
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
984
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K